Terms: = Cervical cancer AND PR, PGR, progesterone receptor
598 results:
1. Sexual Orientation and cervical cancer Screening Among Cisgender Women.
Baumann K; Matzke H; Peterson CE; Geller S; Flores R; Prachand NG; Holt HK
JAMA Netw Open; 2024 May; 7(5):e248886. PubMed ID: 38709536
[TBL] [Abstract] [Full Text] [Related]
2. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Tuninetti V; Virano E; Salutari V; Ricotti A; Pisano C; Ducceschi M; Turitto G; Scandurra G; Petrella MC; Forestieri V; Rizzetto M; Mammoliti S; Artioli G; Cioffi R; Borsotti L; Bellero M; Rognone C; Carbone V; Ferrandina G; Mantiero M; Azzolina C; Geninatti E; Pignata S; Valabrega G
Eur J Cancer; 2024 May; 203():114039. PubMed ID: 38598922
[TBL] [Abstract] [Full Text] [Related]
3. Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of cervical cancer in Pakistan: A Cross-Sectional Study.
Shamsi U; Zahid F; Abdul Jabbar AB; Musharraf MD; Gauhar F; Akbar I; Sherwani M; Bhatti WK; Chaudhary EUH; Sadiq S; Shaikh AN; Shaikh F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):813-820. PubMed ID: 38546064
[TBL] [Abstract] [Full Text] [Related]
4. Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.
Zheng X; Shen F; Chen W; Ren W; Tang S
Abdom Radiol (NY); 2024 May; 49(5):1502-1511. PubMed ID: 38536425
[TBL] [Abstract] [Full Text] [Related]
5. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
[TBL] [Abstract] [Full Text] [Related]
6. Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
Ruiz F; Tjendra Y; Millan N; Gomez-Fernandez C; Pinto A
Am J Surg Pathol; 2024 May; 48(5):546-550. PubMed ID: 38357982
[TBL] [Abstract] [Full Text] [Related]
7. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
[TBL] [Abstract] [Full Text] [Related]
8. Whether specific genetic feature predicted immunotherapy efficacy: A case report.
Chen J; Pang L; He L; Li T; Cheng X
Medicine (Baltimore); 2024 Jan; 103(2):e36922. PubMed ID: 38215117
[TBL] [Abstract] [Full Text] [Related]
9. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
10. Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
Peitz JG; Adebamowo CA; Adebamowo SN
J Nutr; 2024 Feb; 154(2):583-589. PubMed ID: 38158185
[TBL] [Abstract] [Full Text] [Related]
11. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
12. Compliance with Influenza Vaccination and cervical, Breast, and Colorectal cancer Screening in a Sample of Women in Puerto Rico: Community Engagement Efforts from PR-CEAL.
Hill K; Pérez CM; Pons-Calvo A; Canales-Birriel K; López-Cepero A; Solís-Torres N; Tamarit-Quevedo Z; Colón-López V
P R Health Sci J; 2023 Dec; 42(4):318-321. PubMed ID: 38104289
[TBL] [Abstract] [Full Text] [Related]
13. cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
Novais IR; Coelho CO; Machado HC; Surita F; Zeferino LC; Vale DB
PLoS One; 2023; 18(12):e0294956. PubMed ID: 38064494
[TBL] [Abstract] [Full Text] [Related]
14. Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
Tosado-Rodríguez E; Mendez LB; Espino AM; Dorta-Estremera S; Aquino EE; Romaguera J; Godoy-Vitorino F
PLoS One; 2023; 18(12):e0284673. PubMed ID: 38064478
[TBL] [Abstract] [Full Text] [Related]
15. Results of a cluster randomized trial testing the Systems Analysis and Improvement Approach to increase cervical cancer screening in family planning clinics in Mombasa County, Kenya.
Eastment MC; Wanje G; Richardson BA; Mwaringa E; Patta S; Sherr K; Barnabas RV; Mandaliya K; Jaoko W; Mcclelland RS
Implement Sci; 2023 Nov; 18(1):66. PubMed ID: 38012647
[TBL] [Abstract] [Full Text] [Related]
16. Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
Šavrova A; Jaal J; Nõmm O; Innos K
Public Health; 2023 Dec; 225():369-375. PubMed ID: 37989009
[TBL] [Abstract] [Full Text] [Related]
17. Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States.
Dinicu AI; Dioun S; Goldberg M; Crookes DM; Wang Y; Tergas AI
Cancer Med; 2023 Dec; 12(23):21452-21464. PubMed ID: 37964735
[TBL] [Abstract] [Full Text] [Related]
18. Midwives as the Primary Care Providers: Knowledge, Attitude, Practice, and Skill of Early Detection of cervical cancer Using Visual Inspection with Acetic Acid.
Winata IGS; Yusrika MU; Paramitha PP
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3549-3553. PubMed ID: 37898862
[TBL] [Abstract] [Full Text] [Related]
19. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
20. Rechallenge with Anti-PD-1 Inhibitors in Patients with Recurrent Gynecologic Malignancies.
Kim M; Chang CS; Choi MC; Lee JW; Park H; Joo WD
Yonsei Med J; 2023 Oct; 64(10):587-592. PubMed ID: 37727917
[TBL] [Abstract] [Full Text] [Related]
[Next]
